News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
NELSEN ROBERT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
4
| ARCH Venture Partners XII, LLC (10% Owner) has filed a Form 4 on Neumora Therapeutics, Inc.|
Txns:
| Bought 34,000 shares
@ $11.73, valued at
$398.8k
Bought 24,504 shares
@ $12.31, valued at
$301.6k
|
|
| 08/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Prime Medicine, Inc.|
Txns:
| Granted 39,062 options to buy
@ $14.83, valued at
$579.3k
|
|
| 06/12/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 65,000 options to buy
@ $6.7, valued at
$435.5k
|
|
| 05/24/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 01/06/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 536 shares
@ $0 |
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 10/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2022 |
4
| ARCH Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Bought 5,000,000 shares
@ $1.5, valued at
$7.5M
Bought 5,000,000 warrants
@ $1.875, valued at
$9.4M
|
|
| 09/07/2022 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 196,003 shares
@ $0
Disposed of 253,997 shares
@ $0
Acquired 24,737 shares
@ $0
Acquired 1,508 shares
@ $0
Disposed of 239,559 shares
@ $0
Disposed of 310,441 shares
@ $0
Acquired 30,238 shares
@ $0
Acquired 1,850 shares
@ $0 |
|
| 09/01/2022 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0 |
|
| 08/26/2022 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0 |
|
| 08/22/2022 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0 |
|
| 08/16/2022 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0
Acquired 1,684 shares
@ $0
Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 27,489 shares
@ $0 |
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Lyell Immunopharma, Inc.|
Txns:
| Granted 65,000 options to buy
@ $5.31, valued at
$345.2k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/06/2022 |
4
| NELSEN ROBERT (Director) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Granted 230 shares
@ $0 |
|
| 12/22/2021 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 762,233 shares
@ $0
Disposed of 987,767 shares
@ $0
Acquired 102,041 shares
@ $0 |
|
| 12/01/2021 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 29,153 shares
@ $0 |
|
| 11/24/2021 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Disposed of 217,781 shares
@ $0
Disposed of 282,219 shares
@ $0
Acquired 29,153 shares
@ $0 |
|
| 08/09/2021 |
4
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Disposed of 701,250 options to buy
@ $0 |
|
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
3
| ARCH Venture Fund XI, L.P. (10% Owner) has filed a Form 3 on DA32 Life Science Tech Acquisition Corp. |
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
3
| ARCH Venture Partners X, LLC (10% Owner) has filed a Form 3 on Erasca, Inc. |
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|